Pancreatic cancer is among the deadliest cancers. A new drug being tested at Penn is giving patients and doctors hope
A new drug being tested in clinical trials around the world, including at Penn Medicine’s Abramson Cancer Center, is giving hope to pancreatic cancer patients.